Clinical and economic burden of invasive pneumococcal disease in adults: A multicenter hospital-based study

Joon-Young Song, Jun Yong Choi, Jin Soo Lee, In Gyu Bae, Young Keun Kim, Jang Wook Sohn, Yu Mi Jo, Wonseok Choi, Jacob Lee, Kyung Hwa Park, Woo Joo Kim, Hee-Jin Cheong

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Background: Streptococcus pneumoniae causes a broad spectrum of illnesses ranging from mild upper respiratory tract infections to invasive pneumococcal disease (IPD). Quantitative data on the burden of pneumococcal disease, important for the establishment of appropriate vaccination strategies, is currently lacking in adults.Methods: This multicenter, retrospective cohort study was designed to estimate the clinical and economic burden of IPD in adults over the last decade. Data were collected from patients with IPD at 10 university hospitals in South Korea. We estimated the proportion of IPD among all hospitalized patients, the case fatality rate, and the direct medical costs of IPD. Data were further analyzed according to age and risk groups.Results: During the study period, 970 patients with IPD were identified. The mean age for all patients was 60.9 years; patients aged 50-64 years (33.0%) were most numerous, followed by those aged 65-74 years (27.4%). Overall, the proportion of IPD was 0.36 cases/1000 hospitalized patients and the case fatality rate was 30.9%, which increased significantly with age (p < 0.01). The mean direct medical costs were estimated to be US $7,452 without a difference between age and risk groups. On multivariate analysis, old age, advanced ECOG performance status, bacteremic pneumonia, and nosocomial infection were independent risk factors of 30-day case fatality.Conclusions: The clinical disease burden of IPD increased significantly with age and direct medical costs from IPD were substantial, regardless of age and co-morbid conditions. The current age-based vaccination strategy appears to be appropriate.

Original languageEnglish
Article number202
JournalBMC Infectious Diseases
Volume13
Issue number1
DOIs
Publication statusPublished - 2013 May 4

Fingerprint

Economics
Costs and Cost Analysis
Vaccination
Age Groups
Republic of Korea
Mortality
Cross Infection
Streptococcus pneumoniae
Respiratory Tract Infections
Pneumonia
Cohort Studies
Multivariate Analysis
Retrospective Studies

Keywords

  • Cost of illness
  • Pneumococcal infection
  • Pneumococcal vaccines
  • Streptococcus pneumoniae

ASJC Scopus subject areas

  • Infectious Diseases

Cite this

Clinical and economic burden of invasive pneumococcal disease in adults : A multicenter hospital-based study. / Song, Joon-Young; Choi, Jun Yong; Lee, Jin Soo; Bae, In Gyu; Kim, Young Keun; Sohn, Jang Wook; Jo, Yu Mi; Choi, Wonseok; Lee, Jacob; Park, Kyung Hwa; Kim, Woo Joo; Cheong, Hee-Jin.

In: BMC Infectious Diseases, Vol. 13, No. 1, 202, 04.05.2013.

Research output: Contribution to journalArticle

@article{2b17f9f2f4bb416f8a2d80920ff9c7c5,
title = "Clinical and economic burden of invasive pneumococcal disease in adults: A multicenter hospital-based study",
abstract = "Background: Streptococcus pneumoniae causes a broad spectrum of illnesses ranging from mild upper respiratory tract infections to invasive pneumococcal disease (IPD). Quantitative data on the burden of pneumococcal disease, important for the establishment of appropriate vaccination strategies, is currently lacking in adults.Methods: This multicenter, retrospective cohort study was designed to estimate the clinical and economic burden of IPD in adults over the last decade. Data were collected from patients with IPD at 10 university hospitals in South Korea. We estimated the proportion of IPD among all hospitalized patients, the case fatality rate, and the direct medical costs of IPD. Data were further analyzed according to age and risk groups.Results: During the study period, 970 patients with IPD were identified. The mean age for all patients was 60.9 years; patients aged 50-64 years (33.0{\%}) were most numerous, followed by those aged 65-74 years (27.4{\%}). Overall, the proportion of IPD was 0.36 cases/1000 hospitalized patients and the case fatality rate was 30.9{\%}, which increased significantly with age (p < 0.01). The mean direct medical costs were estimated to be US $7,452 without a difference between age and risk groups. On multivariate analysis, old age, advanced ECOG performance status, bacteremic pneumonia, and nosocomial infection were independent risk factors of 30-day case fatality.Conclusions: The clinical disease burden of IPD increased significantly with age and direct medical costs from IPD were substantial, regardless of age and co-morbid conditions. The current age-based vaccination strategy appears to be appropriate.",
keywords = "Cost of illness, Pneumococcal infection, Pneumococcal vaccines, Streptococcus pneumoniae",
author = "Joon-Young Song and Choi, {Jun Yong} and Lee, {Jin Soo} and Bae, {In Gyu} and Kim, {Young Keun} and Sohn, {Jang Wook} and Jo, {Yu Mi} and Wonseok Choi and Jacob Lee and Park, {Kyung Hwa} and Kim, {Woo Joo} and Hee-Jin Cheong",
year = "2013",
month = "5",
day = "4",
doi = "10.1186/1471-2334-13-202",
language = "English",
volume = "13",
journal = "BMC Infectious Diseases",
issn = "1471-2334",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Clinical and economic burden of invasive pneumococcal disease in adults

T2 - A multicenter hospital-based study

AU - Song, Joon-Young

AU - Choi, Jun Yong

AU - Lee, Jin Soo

AU - Bae, In Gyu

AU - Kim, Young Keun

AU - Sohn, Jang Wook

AU - Jo, Yu Mi

AU - Choi, Wonseok

AU - Lee, Jacob

AU - Park, Kyung Hwa

AU - Kim, Woo Joo

AU - Cheong, Hee-Jin

PY - 2013/5/4

Y1 - 2013/5/4

N2 - Background: Streptococcus pneumoniae causes a broad spectrum of illnesses ranging from mild upper respiratory tract infections to invasive pneumococcal disease (IPD). Quantitative data on the burden of pneumococcal disease, important for the establishment of appropriate vaccination strategies, is currently lacking in adults.Methods: This multicenter, retrospective cohort study was designed to estimate the clinical and economic burden of IPD in adults over the last decade. Data were collected from patients with IPD at 10 university hospitals in South Korea. We estimated the proportion of IPD among all hospitalized patients, the case fatality rate, and the direct medical costs of IPD. Data were further analyzed according to age and risk groups.Results: During the study period, 970 patients with IPD were identified. The mean age for all patients was 60.9 years; patients aged 50-64 years (33.0%) were most numerous, followed by those aged 65-74 years (27.4%). Overall, the proportion of IPD was 0.36 cases/1000 hospitalized patients and the case fatality rate was 30.9%, which increased significantly with age (p < 0.01). The mean direct medical costs were estimated to be US $7,452 without a difference between age and risk groups. On multivariate analysis, old age, advanced ECOG performance status, bacteremic pneumonia, and nosocomial infection were independent risk factors of 30-day case fatality.Conclusions: The clinical disease burden of IPD increased significantly with age and direct medical costs from IPD were substantial, regardless of age and co-morbid conditions. The current age-based vaccination strategy appears to be appropriate.

AB - Background: Streptococcus pneumoniae causes a broad spectrum of illnesses ranging from mild upper respiratory tract infections to invasive pneumococcal disease (IPD). Quantitative data on the burden of pneumococcal disease, important for the establishment of appropriate vaccination strategies, is currently lacking in adults.Methods: This multicenter, retrospective cohort study was designed to estimate the clinical and economic burden of IPD in adults over the last decade. Data were collected from patients with IPD at 10 university hospitals in South Korea. We estimated the proportion of IPD among all hospitalized patients, the case fatality rate, and the direct medical costs of IPD. Data were further analyzed according to age and risk groups.Results: During the study period, 970 patients with IPD were identified. The mean age for all patients was 60.9 years; patients aged 50-64 years (33.0%) were most numerous, followed by those aged 65-74 years (27.4%). Overall, the proportion of IPD was 0.36 cases/1000 hospitalized patients and the case fatality rate was 30.9%, which increased significantly with age (p < 0.01). The mean direct medical costs were estimated to be US $7,452 without a difference between age and risk groups. On multivariate analysis, old age, advanced ECOG performance status, bacteremic pneumonia, and nosocomial infection were independent risk factors of 30-day case fatality.Conclusions: The clinical disease burden of IPD increased significantly with age and direct medical costs from IPD were substantial, regardless of age and co-morbid conditions. The current age-based vaccination strategy appears to be appropriate.

KW - Cost of illness

KW - Pneumococcal infection

KW - Pneumococcal vaccines

KW - Streptococcus pneumoniae

UR - http://www.scopus.com/inward/record.url?scp=84876979089&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876979089&partnerID=8YFLogxK

U2 - 10.1186/1471-2334-13-202

DO - 10.1186/1471-2334-13-202

M3 - Article

C2 - 23641904

AN - SCOPUS:84876979089

VL - 13

JO - BMC Infectious Diseases

JF - BMC Infectious Diseases

SN - 1471-2334

IS - 1

M1 - 202

ER -